Kari Hemminki - Epidemiology

Author Information

Kari Hemminki is a prominent researcher in the field of molecular genetic epidemiology, affiliated with the Division of Molecular Genetic Epidemiology at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. His work primarily focuses on cancer research, including the genetic and molecular epidemiology of various cancer types. His extensive research aims to understand the hereditary and environmental factors contributing to cancer risk, with a particular interest in familial cancer syndromes.

Research Contributions

Kari Hemminki has significantly contributed to the understanding of the genetic basis of cancer, particularly in familial colorectal cancer, liver, gallbladder, and bile duct cancers. His recent research has explored germline variants that predispose individuals to familial colorectal cancer and identified novel genetic risk factors through whole-exome sequencing. Additionally, Hemminki's work has examined long-term incidence and survival trends in various cancers across Nordic countries, shedding light on potential etiological factors, such as the historical use of Thorotrast. His research has also delved into the immune landscape of hepatocellular carcinoma, providing insights into prognosis and potential therapeutic targets.

Aliases

Kari Hemminki is also known by aliases such as K Hemminki and K. Hemminki. These variations are often used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	46,427
h-index	97
Total Paper Count	1,408

Publications:

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer

DOI: 10.3390/cancers14030670

Year: 2022

Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?

DOI: 10.1002/ijc.34031

Year: 2022

Functional dissection of inherited non-coding variation influencing multiple myeloma risk

DOI: 10.1038/s41467-021-27666-x

Year: 2022

Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century

DOI: 10.1186/s12885-022-09337-2

Year: 2022

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years

DOI: 10.1371/journal.pone.0261124

Year: 2022

Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.

DOI: 10.1002/ijc.33980

Year: 2022

T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis

DOI: 10.3390/cancers14030604

Year: 2022

Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6.

DOI: 10.1038/s41408-022-00658-w

Year: 2022

Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer

DOI: 10.3390/ijms23031295

Year: 2022

Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country

DOI: 10.3390/cancers14081938

Year: 2022

What is Preprocessing?

How to Assess the Suitability of Complete Case Analysis?

How Can Epidemiologists Use Data from Particulate Matter Sensors?

What Are Some Examples of Successful Infectious Disease Research?

What are the Core Components of Enhanced Education?

Why is NHTSA Important in Epidemiology?

What are the Key Technological Advancements in Epidemiology?

What are the Recommended Levels of Physical Activity?

What Challenges Exist in Implementing Real-Time Updates?

How Can One Benefit from IEA Membership?

Partnered Content Networks

Relevant Topics